Recent Articles from GlobeNewswire

PHILADELPHIA, March 18, 2026 (GLOBE NEWSWIRE) --

Honoring a Decade of Innovation, Plum’s Iconic Explorer Returns: Now with 5G, Starlink® LEO Satellite, and Days of Off-Grid Power

MARLBOROUGH, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a constellation of technology-driven businesses powering the modern energy economy, today announced that it has acquired Harry Kahn Associates, Inc. (“HKA”), an 80‑year‑old defense contractor specializing in mission‑critical technical data systems and lifecycle support for U.S. military platforms. The acquisition was completed through the issuance of 400,000 shares of ConnectM common stock.

PHILADELPHIA, March 18, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or the “Company”) on behalf of investors who purchased or otherwise acquired Beyond Meat securities during the period from February 27, 2025 through November 11, 2025 (the “Class Period”), inclusive.

Online discussion surrounding the conflict shows a high risk of manipulation identified by the Company’s social media analyzing technology

Starting April 15, eXp Realty empowers agents with a distribution pipeline, catapulting ‘Coming Soon’ inventory onto the industry’s most trafficked platforms

Truly’s open casting call gives one friend group an all-expenses-paid getaway where they will star in their own reality miniseries

Covve sharpens its focus on turning in‑person interactions into CRM‑ready, revenue‑driving leads

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- MiningNewsWire Editorial Coverage: Rare earth metallization sits deep in the industrial stack, but it is one of the steps that determines whether advanced manufacturing can actually function at scale. China’s dominance over rare earth refining, metallization and magnet production has left automakers, electronics manufacturers, robotics developers, defense contractors and data-center-adjacent industrial supply chains exposed to a single concentrated source. That exposure helps explain why companies such as REalloys (NASDAQ: ALOY) (MNW Profile News) are drawing attention – The company is working to rebuild a North American mine-to-magnet platform that links feedstock, processing, metallization and magnet manufacturing, with operations centered in Ohio and upstream and midstream partnerships in Saskatchewan, Canada. These efforts will go far to support leading companies such as Advanced Micro Devices Inc. (NASDAQ: AMD), International Business Machines Corporation (NYSE: IBM), Oracle Corporation (NYSE: ORCL) and Meta Platforms Inc. (NASDAQ: META) that rely on these essential metals.

CHICAGO, March 18, 2026 (GLOBE NEWSWIRE) -- Sprout Social (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced a sweep of honors in G2’s 2026 Winter Reports, earning 198 leader badges across all business segments—from small business to enterprise—and spanning every global region.

Inaugural Market Index projects near-full recovery in Q1 2026 deal volume — a signal available now, months before closed deal data catches up

Rudy Wilson to Assume the President and CEO Role

New secure, human-governed AI agent helps privacy teams scale operations and mitigate growing risks.

TORONTO and ARLINGTON, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light” or the “Company”) and Kala Bio, Inc. (NASDAQ: KALA) (“Kala Bio”) today announced that Red Light has engaged Kala Bio’s with its Researgency.ai agentic artificial intelligence platform under world wide license from Younet to support the clinical development strategy for PEX010, the patented botanical psilocybin drug candidate originated by Filament Health Corp. (“Filament”). The engagement will deploy Kala Bio’s purpose-built AI research agents to assist in clinical planning, protocol optimization and scenario modeling as Red Light advances PEX010 through its regulated drug development program.

LiveWorld continues to increase its AI investment

ATLANTA, March 18, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of Kenneth D. Eichenbaum, M.D., M.S.E., to its Board of Directors. Dr. Eichenbaum is a board-certified anesthesiologist with clinical affiliations at Corewell Health William Beaumont University Hospital and Trinity Health Oakland Hospital, bringing deep clinical expertise and strategic insight developed through more than 20 years of evaluating biotechnology and medical device companies and advising investment firms. He completed a fellowship at Stanford University Medical Center and earned his M.D. from the Icahn School of Medicine at Mount Sinai, with additional degrees in engineering from the University of Pennsylvania and in finance from The Wharton School.

Q4 gross margins increased quarterly despite revenue dip

Company Engaged Argentina’s Chief of the Cabinet of Ministers, Provincial Governors, and Leading Enterprises at High-Level Investment Summit Held March 9-12, 2026 in New York City

Silicon Valley, CA, March 18, 2026 (GLOBE NEWSWIRE) -- Resilinc, a leader in supply-chain risk and compliance intelligence, today announced a series of platform advancements that reflect its evolution over the past several months into a cohesive, platform-grade Agent Factory that brings mapping, material flow and agent orchestration together into a single operational platform. These advancements include native support for emerging interoperability standards such as Model Context Protocol (MCP) and Agent-to-Agent (A2A) communication, along with continued investments in validated, agentic mapping and material flow intelligence, with a common data and orchestration foundation to support secure, enterprise-scale deployment. 

How Commercial Fleets Adapted to NYC Congestion Pricing After 12 months

New platform capability enables security teams to discover, assess, and govern AI Skills across AI coding agents and IDEs as the vibe coding ecosystem rapidly expands

CHICAGO, March 18, 2026 (GLOBE NEWSWIRE) -- Opensity Solutions, the tech‑enabled managed services organization supporting legal, financial and professional services firms, today announced the appointment of Jae Cornelssen as Chief Financial Officer. Cornelssen joins Opensity’s executive leadership team at a pivotal stage in the company’s growth, strengthening the financial discipline, governance and strategic rigor required to scale a modern managed services organization.

New research reveals exploitation now occurs within days of disclosure, reinforcing the need for preemptive security operations

Research finds that 9 out of 10 leaders who prioritize innovation reported year-over-year revenue growth, with 51% growing by 10% or more

Selected for oral presentation at Clinical Trials Mini Symposium

Use case-driven, AI-accelerated experience brings critical security workflows to two clicks or less, enabling the move from findings to fixes faster

Milestone case underscores rapidly growing adoption of advanced kidney preservation technology to support transplant outcomes nationwide

ATLANTA, March 18, 2026 (GLOBE NEWSWIRE) -- Fullstory, a leading behavioral data company, today announced significant company acceleration and major product innovations in the second half of its fiscal year. This period was marked by the fastest overall growth in three years, driven by continued upmarket expansion and multi-product traction. Considerable advancements in AI capabilities within its intelligent experience platform have made Fullstory’s AI offering, StoryAI, the fastest-growing expansion offering in the company’s history.

Richmond, Virginia, March 18, 2026 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dawn Von Rohr has been appointed Chief Operating Officer (COO). Von Rohr will oversee Phlow’s operations, manufacturing execution, and strategic growth initiatives as the company continues expanding its advanced pharmaceutical development and manufacturing infrastructure in the United States to strengthen secure domestic production of medicines and active pharmaceutical ingredients (APIs). The appointment reflects Phlow’s continued investment in experienced, world-class operational leadership as the company scales its platform to strengthen domestic pharmaceutical manufacturing, support a more resilient supply chain, and advance pharmaceutical sovereignty. 

MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD), today announced a strategic collaboration with Navidence to help research organizations transform rapidly expanding healthcare data into clear, actionable real-world evidence.

Tender Offer Made in Connection with Parties’ Pending Business Combination Expected to Close Early in the Second Quarter

LOWELL, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, will showcase its latest RF and optoelectronics solutions for satellite communications (SATCOM) at Booth 1637, during SATShow Week, taking place March 24 to 26, 2026 in Washington, D.C. These solutions can enable higher frequency bands, improved power efficiency and more scalable architectures, which are critical to next-generation satellite networks.

Deploys AI (Anthropic Claude, OpenAI) to Slash Costs, Reduce Workforce from 350 to 78 (~19% Reduction this Quarter), Drive All Subsidiaries to Positive Adjusted EBITDA*

PHILADELPHIA, March 18, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC advises shareholders of Walmart Inc. (NASDAQ: WMT) (“Walmart” or the “Company”) about an investigation into Walmart’s Board of Directors (the “Board”) for potential breaches of fiduciary duties owed to the Company and its shareholders regarding whether the Board failed to exercise appropriate oversight and governance in connection with deceptive pay practices for Spark drivers, including base pay, tips, and incentive payments.

Performance Marketing and Brand Stewardship for Company Focused on Supporting Independent Physicians

AIM also intends to pursue Japanese Orphan Drug Designation for Ampligen in treatment of pancreatic cancer

Series A led by Macquarie Capital Venture Capital will fund product expansion and global scale as delivery risk becomes the defining constraint on AI infrastructure, energy and industrial investment

SEATTLE, March 18, 2026 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading AI-powered sales & marketing technology company, will hold a conference call on Tuesday, March 31, 2026, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter ended December 31, 2025, as well as review ongoing initiatives and anticipated milestones.

This article has been disseminated on behalf of LaFleur Minerals Inc. and may include a paid advertisement.

IRVINE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- WallabyPhenox, a global neurovascular medical technology company, today announced the successful completion of a significant financing round aimed at strengthening its financial foundation. The proceeds will be utilized to fully restructure the company’s capital framework and accelerate its long-term global growth initiatives.

Brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use

Incline Village, NV, March 18, 2026 (GLOBE NEWSWIRE) -- Mountain Lake Acquisition Corp. II (Nasdaq: MLAAU) (the “Company”) announced today that, commencing March 19, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “MLAA” and “MLAAW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “MLAAU.”

New Constellation Expands Aleph Observer to Support Persistent Monitoring of Unlimited Locations Worldwide

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the Company will participate in the 38th Annual ROTH Conference being held Sunday, March 22nd to Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, CA.

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced that all proposals put forth at the Special Meeting of Stockholders of CDT, held on Tuesday, March 17, 2026, were duly passed by the stockholders.

DUBLIN and BRIDGEWATER, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, applauded the recommendation that the treatment of CV risk in patients with hypertriglyceridemia be part of a broader dyslipidemia management as discussed in the 2026 American College of Cardiology (ACC) / American Heart Association (AHA)/Multisociety Dyslipidemia Guideline Update.i 

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), today announced that it will release its financial results for the year ended December 31, 2025, on Wednesday, April 2, 2026, prior to the market opening. The Company will host a conference call and simultaneous webcast the same day at 8:30 AM ET.

MAYFIELD VILLAGE, OHIO, March 18, 2026 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended February 28, 2026:

Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction following 90 days of dosing with GT-02287 in individuals with high baseline CSF glucosylsphingosine

Collaboration reinforces a shared commitment to safety, precision, and world-class service at IMG Academy’s Bradenton campus

New research highlights visibility gaps around AI-driven identities, rising NHI risks, and an AI security confidence paradox

Employee-owned regional grocer rolls out integrated loyalty, ecommerce, and digital engagement platform across its network of 44 grocery stores and 24 convenience and fuel locations

• Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit• NIH-funded project leverages collaborators’ expertise in single-molecule proteomics and protein isoform quantification to advance high-resolution cancer isoform analysis

MONTREAL, March 18, 2026 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) announced today that Glenn J. Chamandy, President & Chief Executive Officer, Luca Barile, Executive Vice-President, Chief Financial Officer and Jessy Hayem, Senior Vice-President, Head of Investor Relations and Global Communications will participate in a fireside chat and one-on-one meetings with investors at the 29th Annual CIBC Retail and Consumer Conference in Toronto on Wednesday, March 25, 2026.

Partnership significantly expands global access to Arcana’s breeder-driven genetics through leading online sales platform

New global study of 9,000 respondents reveals how sports moments drive cross-screen engagement, brand discovery, and measurable business impact

Zero Trust leader reports 81% revenue growth, driven by a global shift from perimeter-based tools to identity-driven protection for AI infrastructure and critical systems

Approval marks a historic milestone for Americans living with ssAR who are at high risk for surgery and previously had no dedicated transcatheter treatment option

ION to telecast Finals in May

Listed firms have proven their commitment to equity and advancement for their female employees

WESTLAKE VILLAGE, Calif., and DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present new data from its clinical development program and marketed ZORYVE® (roflumilast) portfolio during the 2026 American Academy of Dermatology (AAD) Annual Meeting taking place March 27-31 in Denver.

Industry specific intelligence bridges the "context gap" with deterministic reasoning, industry Connectors, and enterprise-grade trust

Acquisition Will Add Programmatic Revenue, Rewarded Video Technology and Creator Partnerships While Advancing Platform Capabilities

Former Acronis General Counsel returns to lead corporate development, legal, and strategic initiatives

Burlington, Massachusetts, March 18, 2026 (GLOBE NEWSWIRE) --

Fourth quarter of 2025 revenue increased 70.2% year-over-year to $12.0 million, with record quarterly gross margin of 58.5%

DENVER, CO, March 18, 2026 (GLOBE NEWSWIRE) -- Rank One Computing Corporation d/b/a ROC, (Nasdaq: ROC) (“ROC” or the “Company”), a U.S. leader in multimodal Vision AI, building sovereign biometric, video analytics, and mission intelligence solutions into a unified platform, today announced the Company will ring the Nasdaq Closing Bell at the Nasdaq MarketSite in Times Square, New York, on Thursday, March 19, 2026, to celebrate its milestone listing on the Nasdaq Capital Market. With the support and financial flexibility provided by the capital markets, ROC is well-positioned to deliver on its growth strategy to further augment and scale its leading American Vision AI identity and intelligence platform.

Cambridge, Massachusetts, March 18, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced that it will present two scientific posters at the Alzheimer’s & Parkinson’s Diseases Conference (AD/PD™ 2026), being held March 17–21, 2026 in Copenhagen, Denmark.

BEIJING, March 18, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (the "Company") today announced that its board of directors (the “Board”) has approved an amendment to its existing share repurchase program and a shareholder return target.

Four presentations deliver new insights into zanidatamab, including its differentiated HER2 biology

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Fusemachines Inc. (NASDAQ: FUSE), a leading provider of enterprise Agentic AI technologies, today announced that Talent Connects, a recruiting and talent management platform trusted by more than 300 businesses worldwide, plans to integrate Fusemachines’ Interview Agent into its platform to serve its customers. The planned integration will expand the reach of Fusemachines’ AI-powered interview intelligence, giving Talent Connects customers seamless access to structured interview support directly within their hiring workflows. These AI-powered interview assistants help recruiters conduct more structured, insightful, and efficient candidate interviews.

New patented process empowers communities to align public safety with civil liberties by dynamically retaining vehicle data based on the severity of crime, marking a definitive shift from time-based surveillance to targeted investigation

MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically validated anti-PD1 and IL-2SK to the tumor microenvironment (TME) and anchor it at the tumor site for activation